SLC25A28
gene geneOn this page
Also known as MRS3/4MRS4L
Summary
SLC25A28 (solute carrier family 25 member 28, HGNC:23472) is a protein-coding gene on chromosome 10q24.2, encoding Mitoferrin-2 (Q96A46). Mitochondrial iron transporter that mediates iron uptake. It is a selective cancer dependency (DepMap: 25.8% of cell lines).
Predicted to enable ferrous iron transmembrane transporter activity. Predicted to be involved in iron import into the mitochondrion. Located in mitochondrion.
Source: NCBI Gene 81894 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 37 total
- Cancer dependency (DepMap): dependent in 25.8% of screened cell lines
- MANE Select transcript:
NM_031212
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23472 |
| Approved symbol | SLC25A28 |
| Name | solute carrier family 25 member 28 |
| Location | 10q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MRS3/4, MRS4L |
| Ensembl gene | ENSG00000155287 |
| Ensembl biotype | protein_coding |
| OMIM | 609767 |
| Entrez | 81894 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 8 protein_coding, 2 nonsense_mediated_decay, 2 retained_intron
ENST00000370495, ENST00000434701, ENST00000496035, ENST00000700247, ENST00000700248, ENST00000700249, ENST00000700250, ENST00000700251, ENST00000700252, ENST00000700253, ENST00000913498, ENST00000966520
RefSeq mRNA: 1 — MANE Select: NM_031212
NM_031212
CCDS: CCDS41559
Canonical transcript exons
ENST00000370495 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001452862 | 99620045 | 99620439 |
| ENSE00003259768 | 99610522 | 99611366 |
| ENSE00003633917 | 99613696 | 99613924 |
| ENSE00003637917 | 99612543 | 99612599 |
Expression profiles
Bgee: expression breadth ubiquitous, 275 present calls, max score 98.28.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.3949 / max 215.6569, expressed in 1780 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 110988 | 9.2569 | 1779 |
| 110991 | 0.0873 | 31 |
| 110990 | 0.0377 | 21 |
| 110989 | 0.0130 | 3 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 98.28 | gold quality |
| right testis | UBERON:0004534 | 98.20 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.00 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 97.85 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 97.83 | gold quality |
| lower esophagus | UBERON:0013473 | 97.82 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 97.75 | gold quality |
| granulocyte | CL:0000094 | 97.74 | gold quality |
| tibial nerve | UBERON:0001323 | 97.63 | gold quality |
| right lung | UBERON:0002167 | 97.53 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 97.50 | gold quality |
| left ovary | UBERON:0002119 | 97.48 | gold quality |
| endocervix | UBERON:0000458 | 97.43 | gold quality |
| right ovary | UBERON:0002118 | 97.39 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 97.36 | gold quality |
| left uterine tube | UBERON:0001303 | 97.35 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 97.34 | gold quality |
| skin of abdomen | UBERON:0001416 | 97.29 | gold quality |
| cerebellar cortex | UBERON:0002129 | 97.28 | gold quality |
| body of pancreas | UBERON:0001150 | 97.26 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.23 | gold quality |
| right coronary artery | UBERON:0001625 | 97.18 | gold quality |
| right frontal lobe | UBERON:0002810 | 97.15 | gold quality |
| ectocervix | UBERON:0012249 | 97.14 | gold quality |
| minor salivary gland | UBERON:0001830 | 97.10 | gold quality |
| apex of heart | UBERON:0002098 | 97.10 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 97.09 | gold quality |
| body of uterus | UBERON:0009853 | 97.06 | gold quality |
| body of stomach | UBERON:0001161 | 97.03 | gold quality |
| tibial artery | UBERON:0007610 | 97.03 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.76 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MYC
miRNA regulators (miRDB)
31 targeting SLC25A28, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-6134 | 99.63 | 65.68 | 1537 |
| HSA-MIR-7150 | 99.62 | 66.80 | 1322 |
| HSA-MIR-642A-5P | 99.51 | 65.10 | 1152 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-196A-3P | 99.19 | 67.34 | 1204 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-6768-3P | 99.14 | 67.38 | 1319 |
| HSA-MIR-4763-3P | 99.10 | 67.83 | 2649 |
| HSA-MIR-1233-5P | 98.19 | 66.71 | 1201 |
| HSA-MIR-6778-5P | 98.19 | 66.59 | 1239 |
| HSA-MIR-4768-3P | 98.16 | 66.02 | 2330 |
| HSA-MIR-4736 | 97.96 | 65.89 | 1287 |
| HSA-MIR-6742-3P | 97.95 | 64.50 | 1490 |
| HSA-MIR-12127 | 97.93 | 66.67 | 793 |
| HSA-MIR-665 | 97.60 | 65.64 | 1781 |
| HSA-MIR-558 | 97.50 | 67.16 | 977 |
| HSA-MIR-2278 | 97.30 | 66.19 | 1130 |
| HSA-MIR-7973 | 96.48 | 65.54 | 502 |
| HSA-MIR-4484 | 96.35 | 64.08 | 382 |
| HSA-MIR-3914 | 94.91 | 65.77 | 643 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 25.8% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- Mitoferrin-2-dependent mitochondrial iron uptake sensitizes human head and neck squamous carcinoma cells to photodynamic therapy (PMID:23135267)
- Compares and contrasts all the known human SLC25A* genes and includes functional information. (PMID:23266187)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc25a28 | ENSDARG00000052994 |
| mus_musculus | Slc25a28 | ENSMUSG00000040414 |
| rattus_norvegicus | Slc25a28 | ENSRNOG00000016751 |
Paralogs (49): SLC25A13 (ENSG00000004864), SLC25A5 (ENSG00000005022), SLC25A39 (ENSG00000013306), SLC25A40 (ENSG00000075303), SLC25A3 (ENSG00000075415), SLC25A43 (ENSG00000077713), SLC25A24 (ENSG00000085491), SLC25A1 (ENSG00000100075), SLC25A17 (ENSG00000100372), SLC25A14 (ENSG00000102078), SLC25A15 (ENSG00000102743), SLC25A11 (ENSG00000108528), UCP1 (ENSG00000109424), SLC25A36 (ENSG00000114120), SLC25A12 (ENSG00000115840), SLC25A2 (ENSG00000120329), SLC25A51 (ENSG00000122696), SLC25A16 (ENSG00000122912), SLC25A35 (ENSG00000125434), SLC25A19 (ENSG00000125454), SLC25A23 (ENSG00000125648), SLC25A47 (ENSG00000140107), SLC25A52 (ENSG00000141437), SLC25A38 (ENSG00000144659), SLC25A26 (ENSG00000144741), SLC25A48 (ENSG00000145832), SLC25A37 (ENSG00000147454), SLC25A25 (ENSG00000148339), SLC25A31 (ENSG00000151475), SLC25A4 (ENSG00000151729), SLC25A27 (ENSG00000153291), SLC25A44 (ENSG00000160785), SLC25A45 (ENSG00000162241), SLC25A34 (ENSG00000162461), SLC25A32 (ENSG00000164933), SLC25A6 (ENSG00000169100), SLC25A33 (ENSG00000171612), SLC25A30 (ENSG00000174032), UCP3 (ENSG00000175564), UCP2 (ENSG00000175567)
Protein
Protein identifiers
Mitoferrin-2 — Q96A46 (reviewed: Q96A46)
Alternative names: Mitochondrial RNA-splicing protein 3/4 homolog, Mitochondrial iron transporter 2, Solute carrier family 25 member 28
All UniProt accessions (6): Q96A46, A0A8V8TPH6, A0A8V8TQ16, A0A8V8TQS6, A0A8V8TR30, X6RFA8
UniProt curated annotations — full annotation on UniProt →
Function. Mitochondrial iron transporter that mediates iron uptake. Probably required for heme synthesis of hemoproteins and Fe-S cluster assembly in non-erythroid cells.
Subcellular location. Mitochondrion inner membrane Mitochondrion inner membrane.
Tissue specificity. Ubiquitous. Expressed in placenta, lung, kidney, pancreas, liver, brain, skeletal muscle and heart.
Similarity. Belongs to the mitochondrial carrier (TC 2.A.29) family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96A46-1 | 1 | yes |
| Q96A46-2 | 2 | |
| Q96A46-3 | 3 |
RefSeq proteins (1): NP_112489* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR018108 | MCP_transmembrane | Repeat |
| IPR023395 | MCP_dom_sf | Homologous_superfamily |
Pfam: PF00153
Catalyzed reactions (Rhea), 1 shown:
- Fe(2+)(in) = Fe(2+)(out) (RHEA:28486)
UniProt features (17 total): transmembrane region 6, splice variant 3, repeat 3, region of interest 2, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96A46-F1 | 74.32 | 0.26 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1362409 | Mitochondrial iron-sulfur cluster biogenesis |
| R-HSA-1430728 | Metabolism |
MSigDB gene sets: 240 (showing top):
SHEPARD_BMYB_MORPHOLINO_UP, PAX4_01, GOBP_TRANSITION_METAL_ION_TRANSPORT, FOXO4_01, FOXO1_01, GOBP_IRON_ION_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, PAX8_B, TCF4_Q5, IRF7_01, DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN, GOCC_MITOCHONDRIAL_ENVELOPE, AACTTT_UNKNOWN, RYTTCCTG_ETS2_B, YRTCANNRCGC_UNKNOWN
GO Biological Process (4): iron import into the mitochondrion (GO:0048250), monoatomic ion transport (GO:0006811), iron ion transport (GO:0006826), iron ion transmembrane transport (GO:0034755)
GO Molecular Function (2): ferrous iron transmembrane transporter activity (GO:0015093), iron ion transmembrane transporter activity (GO:0005381)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial membrane (GO:0031966), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| iron ion transmembrane transport | 2 |
| intercellular transport | 1 |
| transport | 1 |
| transition metal ion transport | 1 |
| iron ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| iron ion transmembrane transporter activity | 1 |
| transition metal ion transmembrane transporter activity | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrion | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
944 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC25A28 | ABCB10 | Q9NRK6 | 982 |
| SLC25A28 | ABCB8 | Q9NUT2 | 821 |
| SLC25A28 | FECH | P22830 | 801 |
| SLC25A28 | MTCH1 | Q9NZJ7 | 768 |
| SLC25A28 | FXN | Q16595 | 758 |
| SLC25A28 | ABCB7 | O75027 | 726 |
| SLC25A28 | MTCH2 | Q9Y6C9 | 692 |
| SLC25A28 | NFS1 | Q9Y697 | 663 |
| SLC25A28 | ISCU | Q9H1K1 | 632 |
| SLC25A28 | TFRC | P02786 | 632 |
| SLC25A28 | IREB2 | P48200 | 623 |
| SLC25A28 | SLC11A2 | P49281 | 623 |
| SLC25A28 | ACO1 | P21399 | 602 |
| SLC25A28 | SLC40A1 | Q9NP59 | 562 |
| SLC25A28 | LYRM4 | Q9HD34 | 561 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC15A1 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC2A12 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| PDCD1 | RTL8C | psi-mi:“MI:0914”(association) | 0.530 |
| SLC25A28 | BDKRB1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PDCD1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| GPR182 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| GPR12 | TLCD2 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC2A9 | HIP1R | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (40): SLC25A28 (Affinity Capture-MS), SLC25A28 (Affinity Capture-MS), SLC25A28 (Affinity Capture-MS), ALDH1B1 (Affinity Capture-MS), ATP1A1 (Affinity Capture-MS), ATP1B3 (Affinity Capture-MS), ATP6V1H (Affinity Capture-MS), CLPB (Affinity Capture-MS), COG5 (Affinity Capture-MS), DNAJB6 (Affinity Capture-MS), DPM1 (Affinity Capture-MS), ETFA (Affinity Capture-MS), FARSA (Affinity Capture-MS), GCDH (Affinity Capture-MS), HAX1 (Affinity Capture-MS)
ESM2 similar proteins: A0JN87, A6QR09, F1R4U0, F1RFX9, O22261, O43772, O43808, O70579, O77792, O95258, O97562, O97649, P55851, P55916, P56499, P56501, P70406, P97521, Q08DK4, Q287T7, Q3SZI5, Q4V9P0, Q5R5A8, Q5RD81, Q5RFB7, Q5U680, Q5ZKP7, Q641C8, Q66H23, Q6DG32, Q6GLA2, Q6IZB5, Q70HW3, Q8BMG8, Q8HXY2, Q8R0Z5, Q920G8, Q922G0, Q95J75, Q96A46
Diamond homologs: A0A1D6N272, A1DI57, A2A3V2, A2ASZ8, A2CEQ0, A2R5A0, A3LVX1, A4RF23, A5DIS9, A5DX39, A6RF73, A6SL61, A6ZV78, A7ER02, A7TDX5, B4F8I5, B4FIJ0, B8ZHC9, F4JU70, O04200, O04619, O22261, O43808, O59674, O60029, O70579, O94370, O97649, P04710, P0C546, P10861, P16260, P16261, P25874, P29518, P53257, P55916, Q01888, Q05AQ3, Q08DK7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
37 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 32 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
986 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:99611457:A:T | acceptor_gain | 1.0000 |
| 10:99611459:CCAA:C | acceptor_gain | 1.0000 |
| 10:99611460:C:T | acceptor_gain | 1.0000 |
| 10:99611462:A:AC | acceptor_gain | 1.0000 |
| 10:99611467:A:AC | acceptor_gain | 1.0000 |
| 10:99613740:AATGT:A | donor_gain | 1.0000 |
| 10:99613753:A:C | donor_gain | 1.0000 |
| 10:99613836:AGGC:A | donor_gain | 1.0000 |
| 10:99613851:ATAAT:A | donor_gain | 1.0000 |
| 10:99611413:G:T | acceptor_gain | 0.9900 |
| 10:99611451:C:CT | acceptor_gain | 0.9900 |
| 10:99611452:A:T | acceptor_gain | 0.9900 |
| 10:99611456:C:CT | acceptor_gain | 0.9900 |
| 10:99611460:CAA:C | acceptor_gain | 0.9900 |
| 10:99611461:A:T | acceptor_gain | 0.9900 |
| 10:99611462:A:C | acceptor_gain | 0.9900 |
| 10:99611467:A:C | acceptor_gain | 0.9900 |
| 10:99612537:CATTA:C | donor_loss | 0.9900 |
| 10:99612538:ATTAC:A | donor_loss | 0.9900 |
| 10:99612539:TTA:T | donor_loss | 0.9900 |
| 10:99612540:TA:T | donor_loss | 0.9900 |
| 10:99612541:AC:A | donor_loss | 0.9900 |
| 10:99612542:C:CT | donor_loss | 0.9900 |
| 10:99612599:CCTGC:C | acceptor_loss | 0.9900 |
| 10:99612600:C:A | acceptor_loss | 0.9900 |
| 10:99612601:T:A | acceptor_loss | 0.9900 |
| 10:99613156:A:AC | donor_gain | 0.9900 |
| 10:99613157:C:CC | donor_gain | 0.9900 |
| 10:99613740:A:AC | donor_gain | 0.9900 |
| 10:99613741:A:C | donor_gain | 0.9900 |
AlphaMissense
2351 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:99610917:A:G | W343R | 1.000 |
| 10:99610917:A:T | W343R | 1.000 |
| 10:99611086:T:A | K286N | 1.000 |
| 10:99611086:T:G | K286N | 1.000 |
| 10:99611120:G:T | A275D | 1.000 |
| 10:99613769:A:C | F149L | 1.000 |
| 10:99613769:A:T | F149L | 1.000 |
| 10:99613771:A:G | F149L | 1.000 |
| 10:99610925:G:T | A340D | 0.999 |
| 10:99610952:C:A | R331I | 0.999 |
| 10:99610964:C:T | G327E | 0.999 |
| 10:99610965:C:A | G327W | 0.999 |
| 10:99610965:C:G | G327R | 0.999 |
| 10:99610965:C:T | G327R | 0.999 |
| 10:99611074:G:C | N290K | 0.999 |
| 10:99611074:G:T | N290K | 0.999 |
| 10:99611078:A:G | L289P | 0.999 |
| 10:99611081:A:G | L288P | 0.999 |
| 10:99611087:T:A | K286I | 0.999 |
| 10:99611088:T:C | K286E | 0.999 |
| 10:99611089:G:C | C285W | 0.999 |
| 10:99611090:C:T | C285Y | 0.999 |
| 10:99611091:A:G | C285R | 0.999 |
| 10:99611096:T:A | D283V | 0.999 |
| 10:99611096:T:C | D283G | 0.999 |
| 10:99611097:C:G | D283H | 0.999 |
| 10:99611102:G:C | P281R | 0.999 |
| 10:99611102:G:T | P281Q | 0.999 |
| 10:99611117:G:T | A276D | 0.999 |
| 10:99611126:G:T | A273D | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000008686 (10:99621989 G>T), RS1000122077 (10:99632335 C>T), RS1000200706 (10:99640979 G>T), RS1000204129 (10:99634223 A>G), RS1000279297 (10:99615286 G>A,C), RS1000365744 (10:99648063 A>C), RS1000378129 (10:99655087 A>C), RS1000408749 (10:99632821 C>A,T), RS1000515694 (10:99637643 G>A), RS1000568083 (10:99637904 A>G), RS1000587564 (10:99646738 G>A), RS1000654253 (10:99648454 T>C), RS1000714011 (10:99653437 C>T), RS1000719162 (10:99641337 T>C), RS1000745914 (10:99656547 T>C)
Disease associations
OMIM: gene MIM:609767 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001438_10 | Crohn’s disease | 5.000000e-07 |
| GCST001800_9 | β2-Glycoprotein I (β2-GPI) plasma levels | 2.000000e-06 |
| GCST002411_7 | Colorectal cancer | 5.000000e-11 |
| GCST002919_10 | Colorectal cancer | 8.000000e-07 |
| GCST003017_4 | Colorectal cancer | 8.000000e-07 |
| GCST003017_9 | Colorectal cancer | 4.000000e-08 |
| GCST006479_115 | Diverticular disease | 1.000000e-11 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004555 | glycoprotein measurement |
| EFO:0009959 | diverticular disease |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC25 mitochondrial iron transporters subfamily
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects cotreatment, decreases reaction, increases expression, decreases methylation | 6 |
| bisphenol A | increases methylation, decreases expression | 2 |
| Arsenic Trioxide | decreases expression, increases expression | 2 |
| Acetaminophen | decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| 1,6-hexamethylene diisocyanate | increases methylation | 1 |
| afimoxifene | decreases reaction, increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| ICG 001 | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | affects cotreatment, decreases reaction, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases abundance, increases methylation | 1 |
| Ethanol | affects cotreatment, decreases reaction, increases expression | 1 |
| Vehicle Emissions | increases abundance, increases methylation | 1 |
| Environmental Pollutants | affects expression | 1 |
| Estrogens | decreases reaction, increases expression | 1 |
| Lipopolysaccharides | increases expression, affects response to substance | 1 |
| Nickel | increases expression | 1 |
| Nitrogen Dioxide | increases abundance, increases methylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Cellosaurus cell lines
8 cell lines: 6 cancer cell line, 2 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1HL | Abcam A-549 SLC25A28 KO 2 | Cancer cell line | Male |
| CVCL_B2Q4 | Abcam A-549 SLC25A28 KO 1 | Cancer cell line | Male |
| CVCL_D4DY | HEK-SLC25A28-KO-c1 | Transformed cell line | Female |
| CVCL_D4DZ | HEK-SLC25A28-KO-c10 | Transformed cell line | Female |
| CVCL_D4JP | HCT116-SLC25A28-KO-c3 | Cancer cell line | Male |
| CVCL_D4JQ | HCT116-SLC25A28-KO-c9 | Cancer cell line | Male |
| CVCL_TM28 | HAP1 SLC25A28 (-) 1 | Cancer cell line | Male |
| CVCL_XT04 | HAP1 SLC25A28 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.